Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 6/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.33 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.32 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.32 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.30 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13487883 | 0.93 | PDK2 (0.35) | PDK2PLA2G2APLA2G4APLA2G10 | |
| SCHEMBL13488109 | 0.91 | PDK2 (0.32) | PDK2PLA2G2APLA2G4APLA2G10ALOX5 | |
| SCHEMBL22947386 | 0.90 | PDK2 (0.34) | PDK2CASP3SENP7SENP6HCRTR1 | |
| SCHEMBL20277477 | 0.89 | ALOX5 (0.39) | PDK2ALOX5CASP3SENP7SENP6 | |
| SCHEMBL13487730 | 0.88 | ALK (0.31) | PDK2ALK | |
| SCHEMBL13150222 | 0.88 | ALOX5 (0.32) | PLA2G2APLA2G4APLA2G10ALOX5 | |
| SCHEMBL24564228 | 0.87 | PDK2 (0.33) | PDK2PLA2G2APLA2G4AALK | |
| SCHEMBL26404244 | 0.87 | PLA2G2A (0.37) | PDK2PLA2G2APLA2G4APLA2G10CASP3 | |
| SCHEMBL13487342 | 0.87 | PDK2 (0.31) | PDK2ALOX5 | |
| SCHEMBL13487887 | 0.87 | PLA2G2A (0.38) | PDK2PLA2G2APLA2G4APLA2G10CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230183200-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD (KR) | 2023-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183200-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | TRPA1, CRY2, SUN2 | PDK2 1839/4885PLA2G2A 1982/4885PLA2G4A 2445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.